Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

Saudi Arabia · Delayed Price · Currency is SAR

128.00

-1.30 (-1.01%)

At close: Mar 3, 2026

Revenue by Segment

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceutical Products	1.14B	956.73M	797.38M	663.46M	731.16M
Pharmaceutical Products Growth	19.09%	19.98%	20.18%	-9.26%	-
Consumer Health Products	179.07M	144.09M	119.30M	72.22M	74.15M
Consumer Health Products Growth	24.28%	20.78%	65.18%	-2.60%	-
Total	1.32B	1.10B	916.67M	735.68M	805.31M
Total Growth	19.77%	20.09%	24.60%	-8.65%	-

Revenue by Geography

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Kingdom of Saudi Arabia	857.67M	720.59M	587.13M	466.10M	538.68M
Kingdom of Saudi Arabia Growth	19.02%	22.73%	25.97%	-13.47%	6.19%
Gulf	181.68M	139.93M	108.70M	73.27M	92.96M
Gulf Growth	29.84%	28.73%	48.35%	-21.18%	-
Iraq	116.19M	105.14M	91.15M	64.58M	51.49M
Iraq Growth	10.51%	15.34%	41.14%	25.42%	-
Egypt	70.60M	59.24M	64.17M	67.04M	59.04M
Egypt Growth	19.18%	-7.69%	-4.28%	13.55%	-
North Africa and Other Export Markets	92.34M	75.93M	65.52M	64.69M	63.15M
North Africa and Other Export Markets Growth	21.61%	15.89%	1.28%	2.44%	-
Total	1.32B	1.10B	916.67M	735.68M	805.31M
Total Growth	19.77%	20.09%	24.60%	-8.65%	10.06%

Source: S&P Global Market Intelligence.